Multicenter clinical study on the efficacy and safety with extensive and repeated injections of cultured (human) autologous hair follicle dermal sheath cup cells on male and female pattern hair loss

Harada Kazutoshi0 个研究点目标入组 36 人开始时间: 2020年10月13日最近更新: 2023年10月17日

试验速览

暂无简介。

•1. Male or female of 20 year old or more with in good health having pattern hair loss involving the vertex area of the scalp.
•2. Male subjects with pattern hair loss characterized as type III vertex to type VI on the Norwood Scale, or equivalent type. Female subjects with pattern hair loss characterized as type 3 to type 6 of the Shiseido Scale.
•3. Subjects with willingness to provide written informed consent for participation in the study, to attend all study visits and to complete all procedures required by this protocol.
•4. Subjects with willingness to forego the use quasi drug or medical products for hair growth throughout the course of the study.

•1. Use of any product (medication or otherwise) which interferes with the hair growth cycle.
•2. Any systemic medical treatment or quasi drug for hair growth within six months prior to obtaining the Informed Consent. Or those who underwent hair loss therapies by LED and/or low power output of raiser radiation within six months prior to obtaining the Informed Consent.
•3. Presence of any medical condition that influences the hair growth cycle.
•4. Infection with viruses such as HBV, HCV, HIV, adult T-cell leukemia, parvovirus or VDS has been confirmed by virological examination and syphilis testing carried out at the time of the screening.

发起方

Harada Kazutoshi